The Corporate Roundtable

The Corporate Roundtable (CRT) was created to establish a relationship between the AAN, AAN Foundation, and Industry. The CRT is an AAN Foundation-sponsored membership organization of companies that are committed to working together with the neurological community to meet the following AAN Foundation goals:

  • Stimulate broad-based support to improve quality of care and quality of life for people with neurological disease
  • Promote research and public education in the neurosciences
  • Advance public understanding of disorders of the brain

2012 Corporate Roundtable Members

$40,000






$30,000

  • IPSEN
  • Biogen Idec
  •        

$20,000

     
  • Acorda Therapeutics, Inc.
  •  
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  •  
  • Forest Laboratories, Inc.
  •  
  • Genentech
  •  
  • Merck & Co., Inc.
  •  
  • Merz Pharmaceuticals, LLC
  •  
  • Pfizer Inc
  •  
  • PhotoThera, Inc.
  •      
  • Purdue Pharma L.P.
  •      
  • Questcor Pharmaceuticals, Inc.
  •      
  • Upsher-Smith Laboratories, Inc.
     

Current as of January 11, 2012

2012 Corporate Roundtable Member Benefits

For More Information
Alberta Zais

Director, Corporate Relations
azais@aan.com
(651) 695-2760

Bridget Farley

Manager, Corporate Relations
bfarley@aan.com
(651) 695-2703

Kristine Retka

Senior Administrator, Corporate Relations
kretka@aan.com
(651) 695-2787